MVs and MVs-Crocin as Novel Therapeutic Agents for Lung Cancer, Apoptosis, and Gene Regulation

Hosein Keshavaerz1, Bita Zand1, Leila Sadat Nilchiani1

  • 1Department of cellular and molecular Biology, TeMS.C, Islamic Azad University, Tehran Medical Sciences, Tehran, Iran.

Abstract

Insights

Mesenchymal stem cell-derived microvesicles (MVs), especially when preconditioned with Crocin (MVs-Crocin), effectively reduce lung cancer cell survival and induce apoptosis. These findings highlight MVs as promising agents for novel lung cancer therapies.

Area of Science:

  • Biotechnology
  • Cancer Research
  • Cell Biology

Background:

  • Lung cancer remains a leading global malignancy.
  • Mesenchymal stem cells and their derivatives show potential in cancer therapy.
  • This study explores microvesicles (MVs) from stem cells and Crocin-preconditioned MVs (MVs-Crocin) against lung cancer cells.

Purpose of the Study:

  • To evaluate the anti-cancer effects of MVs and MVs-Crocin on A549 lung cancer cells.
  • To compare the efficacy of MVs and MVs-Crocin against normal HEK293 cells.
  • To investigate the mechanism of action, focusing on apoptosis induction.

Main Methods:

  • Mesenchymal stem cells were preconditioned with Crocin.
  • Microvesicles (MVs) and MVs-Crocin were isolated and their optimal concentrations determined via MTT assay.
  • Lung cancer (A549) and normal (HEK293) cells were treated, followed by apoptosis assessment (flow cytometry) and gene expression analysis (real-time PCR).

Main Results:

  • Optimal concentrations were identified as 40 μg/ml for MVs and 50 μg/ml for MVs-Crocin.
  • Both MVs and MVs-Crocin significantly decreased A549 cell viability.
  • Apoptosis assays and gene expression data confirmed increased apoptosis in treated cancer cells.

Conclusions:

  • MVs and MVs-Crocin exhibit significant anti-cancer properties against lung cancer cells.
  • Crocin preconditioning enhances the therapeutic potential of MVs.
  • The observed effects are more pronounced in cancer cells, suggesting selective therapeutic action.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.7K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.3K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
3.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K